{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:56:05Z","timestamp":1794372965581,"version":"4.9.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.tvjl.2011.05.010","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T22:17:18Z","timestamp":1308521838000},"page":"239-241","source":"Crossref","is-referenced-by-count":31,"title":["Pharmacokinetics of mirtazapine and its main metabolites in Beagle dogs: A pilot study"],"prefix":"10.1016","volume":"192","author":[{"given":"Mario","family":"Giorgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2011.05.010_b0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuropharm.2004.09.012","article-title":"Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain","volume":"48","author":"Bomholt","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tvjl.2011.05.010_b0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.phrs.2009.02.006","article-title":"Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers","volume":"59","author":"Borobia","year":"2009","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.tvjl.2011.05.010_b0015","first-page":"34","article-title":"Mirtazapine as an antiemetic","volume":"23","author":"Cahill","year":"2006","journal-title":"Veterinary Forum"},{"key":"10.1016\/j.tvjl.2011.05.010_b0020","first-page":"19","article-title":"The pharmacologic profile of mirtazapine","volume":"13","author":"de Boer","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.tvjl.2011.05.010_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00044011-199815010-00006","article-title":"Pharmacokinetics and biotransformation of mirtazapine in human volunteers","volume":"15","author":"Delbressine","year":"1998","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.tvjl.2011.05.010_b0030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2460\/javma.1991.199.04.457","article-title":"Evaluation of the safety of ivermectin administered in a beef-based formulation to ivermectin-sensitive Collies","volume":"199","author":"Fassler","year":"1991","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2011.05.010_b0035","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2460\/javma.233.12.1902","article-title":"Use of trazodone as an adjunctive agent in the treatment of canine anxiety disorders: 56 cases (1995\u20132007)","volume":"233","author":"Gruen","year":"2008","journal-title":"Journal of American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2011.05.010_b0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0168-1591(99)00127-6","article-title":"Treatment of separation anxiety in dogs with clomipramine: Results from a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial","volume":"67","author":"King","year":"2000","journal-title":"Applied Animal Behaviour Science"},{"key":"10.1016\/j.tvjl.2011.05.010_b0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.aca.2005.09.049","article-title":"Determination of the antidepressant mirtazapine and its two main metabolites in human plasma by liquid chromatography with fluorescence detection","volume":"556","author":"Mandrioli","year":"2006","journal-title":"Analytica Chimica Acta"},{"key":"10.1016\/j.tvjl.2011.05.010_b0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0278-5846(00)00104-4","article-title":"Natural animal models of human psychiatric conditions: Assessment of mechanism and validity","volume":"24","author":"Overall","year":"2000","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.tvjl.2011.05.010_b0050","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2885.2010.01244.x","article-title":"Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats","author":"Quimby","year":"2011","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2011.05.010_b0055","first-page":"18","article-title":"Effects of reconcile (fluoxetine) chewable tablets plus behavior management for canine separation anxiety","volume":"8","author":"Simpson","year":"2007","journal-title":"Veterinary Therapy"},{"key":"10.1016\/j.tvjl.2011.05.010_b0060","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0026-895X(24)12045-7","article-title":"Metabolism of the antidepressant mirtazapine in vitro: Contribution of cytochromes P-450 1A2, 2D6, and 3A4","volume":"28","author":"St\u00f6rmer","year":"2000","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tvjl.2011.05.010_b0065","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1002\/hup.470100804","article-title":"Pharmacokinetic dose-proportionality study at steady state of mirtazapine from Remeron tablets","volume":"10","author":"Timmer","year":"1995","journal-title":"Human Psychopharmacology"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023311001833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023311001833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T10:41:40Z","timestamp":1741257700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023311001833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1090023311001833"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2011.05.010","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}